Literature DB >> 9237672

Cloning and functional expression of human kynurenine 3-monooxygenase.

D Alberati-Giani1, A M Cesura, C Broger, W D Warren, S Röver, P Malherbe.   

Abstract

Kynurenine 3-monooxygenase, an NADPH-dependent flavin monooxygenase, catalyses the hydroxylation of L-kynurenine to L-3-hydroxykynurenine. By hybridization screening using a cDNA probe encoding the entire exon 2 of Drosophila melanogaster kynurenine 3-monooxygenase, we isolated a 2.0 kb cDNA clone coding for the corresponding human liver enzyme. The deduced amino acid sequence of the human protein consists of 486 amino acids with a predicted molecular mass of 55,762 Da. Transfection of the human cDNA in HEK-293 cells resulted in the functional expression of the enzyme with kinetic properties similar to those found for the native human protein. RNA blot analysis of human tissues revealed the presence of a major mRNA species of approximately 2.0 kb in liver, placenta and kidney.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9237672     DOI: 10.1016/s0014-5793(97)00627-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

1.  Purification and molecular cloning of rat 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase.

Authors:  Atsushi Tanabe; Yukari Egashira; Shin-Ichi Fukuoka; Katsumi Shibata; Hiroo Sanada
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

Review 2.  The emerging role of aryl hydrocarbon receptor in the activation and differentiation of Th17 cells.

Authors:  Eszter Baricza; Viola Tamási; Nikolett Marton; Edit I Buzás; György Nagy
Journal:  Cell Mol Life Sci       Date:  2015-10-28       Impact factor: 9.261

Review 3.  NAD(H) and NADP(H) Redox Couples and Cellular Energy Metabolism.

Authors:  Wusheng Xiao; Rui-Sheng Wang; Diane E Handy; Joseph Loscalzo
Journal:  Antioxid Redox Signal       Date:  2017-07-28       Impact factor: 8.401

4.  Transcriptional Regulation of RUNX1: An Informatics Analysis.

Authors:  Amarni L Thomas; Judith Marsman; Jisha Antony; William Schierding; Justin M O'Sullivan; Julia A Horsfield
Journal:  Genes (Basel)       Date:  2021-07-29       Impact factor: 4.096

Review 5.  Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease.

Authors:  Robert Schwarcz; Paolo Guidetti; Korrapati V Sathyasaikumar; Paul J Muchowski
Journal:  Prog Neurobiol       Date:  2009-04-24       Impact factor: 11.685

Review 6.  The causative role and therapeutic potential of the kynurenine pathway in neurodegenerative disease.

Authors:  Marta Amaral; Tiago F Outeiro; Nigel S Scrutton; Flaviano Giorgini
Journal:  J Mol Med (Berl)       Date:  2013-05-01       Impact factor: 4.599

Review 7.  Advantages of brain penetrating inhibitors of kynurenine-3-monooxygenase for treatment of neurodegenerative diseases.

Authors:  Shaowei Zhang; Mary E W Collier; Derren J Heyes; Flaviano Giorgini; Nigel S Scrutton
Journal:  Arch Biochem Biophys       Date:  2020-12-01       Impact factor: 4.013

Review 8.  The Kynurenine Pathway and Kynurenine 3-Monooxygenase Inhibitors.

Authors:  Tamera D Hughes; Osman F Güner; Emma Carine Iradukunda; Robert S Phillips; J Phillip Bowen
Journal:  Molecules       Date:  2022-01-02       Impact factor: 4.411

Review 9.  Tryptophan metabolism, disposition and utilization in pregnancy.

Authors:  Abdulla A-B Badawy
Journal:  Biosci Rep       Date:  2015-09-17       Impact factor: 3.840

10.  Overexpression of human kynurenine-3-monooxygenase protects against 3-hydroxykynurenine-mediated apoptosis through bidirectional nonlinear feedback.

Authors:  K Wilson; M Auer; M Binnie; X Zheng; N T Pham; J P Iredale; S P Webster; D J Mole
Journal:  Cell Death Dis       Date:  2016-04-14       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.